CTSO
Cytosorbents Corp

2,141
Mkt Cap
$42.14M
Volume
9,471.00
52W High
$1.61
52W Low
$0.60
PE Ratio
-3.53
CTSO Fundamentals
Price
$0.67
Prev Close
$0.671
Open
$0.68
50D MA
$0.6881
Beta
0.76
Avg. Volume
74,147.25
EPS (Annual)
-$0.3806
P/B
4.67
Rev/Employee
$238,889.40
Loading...
Loading...
News
all
press releases
What Analysts Are Saying About CytoSorbents Stock
read more...
Benzinga·29d ago
News Placeholder
More News
News Placeholder
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and...
PR Newswire·29d ago
News Placeholder
CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025
CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025 CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday...
PR Newswire·2mo ago
News Placeholder
Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London
Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London PR Newswire...
PR Newswire·3mo ago
News Placeholder
CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update
CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update PR Newswire PRINCETON...
PR Newswire·3mo ago
News Placeholder
CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London
CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London PR Newswire PRINCETON, N.J...
PR Newswire·3mo ago
News Placeholder
CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights
CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights PR Newswire...
PR Newswire·3mo ago
News Placeholder
In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer
In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer In Memoriam: Dr. Robert Hawes Bartlett...
PR Newswire·4mo ago
<
...
1
>

Latest CTSO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.